| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 2.7 | $0-$5k | 0.00 |
Summary
A vulnerability was found in Oracle VirtualBox 7.2.16 and classified as problematic. Affected is an unknown function of the component Core. The manipulation results in information disclosure. This vulnerability is known as CVE-2026-87281. Attacking locally is a requirement. No exploit is available.
Details
A vulnerability classified as problematic has been found in Oracle VirtualBox 7.2.16. Affected is an unknown code of the component Core. The manipulation with an unknown input leads to a information disclosure vulnerability. CWE is classifying the issue as CWE-200. The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information. This is going to have an impact on confidentiality. CVE summarizes:
Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core). The supported version that is affected is 7.2.16. Easily exploitable vulnerability allows high privileged attacker with logon to the infrastructure where Oracle VM VirtualBox executes to compromise Oracle VM VirtualBox. While the vulnerability is in Oracle VM VirtualBox, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle VM VirtualBox accessible data. CVSS 3.1 Base Score 3.2 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:L/I:N/A:N).
The advisory is shared for download at oracle.com. This vulnerability is traded as CVE-2026-87281 since 09/08/2026. The exploitability is told to be easy. The attack needs to be approached locally. The exploitation requires an enhanced level of successful authentication. There are neither technical details nor an exploit publicly available. The current price for an exploit might be approx. USD $0-$5k (estimation calculated on 09/16/2026). The MITRE ATT&CK project declares the attack technique as T1592.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 2.7VulDB Meta Temp Score: 2.7
VulDB Base Score: 2.3
VulDB Temp Score: 2.3
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 3.2
CNA Vector (oracle): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Information disclosureCWE: CWE-200 / CWE-284 / CWE-266
CAPEC: 🔒
ATT&CK: 🔒
Physical: Partially
Local: Yes
Remote: No
Availability: 🔒
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
09/08/2026 CVE reserved09/16/2026 Advisory disclosed
09/16/2026 VulDB entry created
09/16/2026 VulDB entry last update
Sources
Vendor: oracle.comAdvisory: oracle.com
Status: Confirmed
CVE: CVE-2026-87281 (🔒)
GCVE (CVE): GCVE-0-2026-87281
GCVE (VulDB): GCVE-100-405360
Entry
Created: 09/16/2026 02:37Changes: 09/16/2026 02:37 (61)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.